HOME - The Journal of Precision Medicine

LATEST NEWS

Mission Bio Announces Yan Zhang as New CEO

adminpmls20162021-04-09T09:21:40-05:00April 9th, 2021|

Diagnostic Laboratory Services, Inc. (DLS) Launches New Precision Medicine Program with GenomOncology’s Pathology Workbench

adminpmls20162021-04-09T09:18:18-05:00April 9th, 2021|

Cancer-Killing Virus Therapy Shows Promise Against Inoperable Skin Cancers

adminpmls20162021-04-09T09:08:23-05:00April 9th, 2021|

Invitae to acquire Genosity to accelerate access to personalized oncology testing worldwide

adminpmls20162021-04-09T09:02:47-05:00April 9th, 2021|

Magellan Rx Management and Trapelo Health to Offer Precision Oncology Platform for Next-Generation Care

adminpmls20162021-04-09T08:58:24-05:00April 9th, 2021|

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s and bluebird bio’s Abecma (idecabtagene vicleucel), the First Anti-BCMA CAR T Cell Therapy for Relapsed or Refractory Multiple Myeloma

adminpmls20162021-04-01T15:24:10-05:00April 1st, 2021|

Delfi Diagnostics Begins Enrollment for Prospective Lung Cancer Screening Trial ahead of Planned Commercial Test

adminpmls20162021-04-01T15:20:10-05:00April 1st, 2021|

SomaLogic, Leading AI-Data Driven Proteomics Platform for Advanced Research and Clinical applications, to Combine with CM Life Sciences II, to Drive Growth and Expand Technology Platform

adminpmls20162021-04-01T15:16:55-05:00April 1st, 2021|

Genome Medical Expands Board of Directors and Leadership Team as Demand for Genomics Telehealth Services Grows

adminpmls20162021-04-01T15:13:13-05:00April 1st, 2021|

Mission Bio Announces Yan Zhang as New CEO - thejournalofprecisionmedicine.com/mission-bio-an…
1 day ago
Diagnostic Laboratory Services, Inc. (DLS) Launches New Precision Medicine Program with GenomOncology's Pathology W… twitter.com/i/web/status/1…
1 day ago
Cancer-Killing Virus Therapy Shows Promise Against Inoperable Skin Cancers - thejournalofprecisionmedicine.com/cancer-killing…
1 day ago

LATEST ISSUE

The Journal of Precision Medicine - March

Integrating biomarker and translational research in a drug development pipeline

New Disruptive Business Model: The Convergence of Precision Science, Precision Medicine, Precision Product Development, and Precision Commercialization

Industry challenges & opportunities for the integration of precision medicine tools at the point of care

Building Back Better: Leveraging Value-Based Payment to Build a More Resilient Health Care System

Questions on an agnostic AI system: A case study for an aortic aneurysm detection and other applications

Implementing the ACMG Guidelines for CNV in a Commercial Software Solution

Revitalizing pharma’s drug discovery pipelines

The Parallel Diagnostic Odysseys of Alzheimer’s Disease and NASH

Multidimensional Predictive Diagnostics: The GPS of Clinical Practice

The Human Touch: Improving In Vivo Evaluation of Biologics with Human-ized Immune System Models

From Cerebral Cavernous Malformation to cancer research: a one-size-fits-all path to precision medicines

Letter to the Journal: The COVID-19 innovation race, a case study

Personalized Medicine and Disease Modification in Osteoarthritis: On our journey but still a way to go!

ARCHIVE ISSUES

The Journal of Precision Medicine - December

December 2020

Articles include:
Letter to the Journal: The COVID-19 innovation race, a case study
Personalised Medicine and Disease Modification in Osteoarthritis: On our journey but still a way to go!

Read More

The Journal of Precision Medicine - September

September 2020

Articles include:
Cell and gene therapy: OVERVIEW, CURRENT LANDSCAPE AND FUTURE TRENDS
Pioneering precision medicine in rheumatoid arthritis

Read More

The Journal of Precision Medicine - June

June 2020

Articles include:
Using tears for precision diagnostics and the development of a potential new therapy for age- related macular degeneration
The dal-GenE trial: A case study of precision medicine in the cardiovascular setting

Read More

March 2020

Articles include:
Personalized Medicine in the Aftermath of COVID-19
Quick takes: Q&A with Jeff Evelhoch on Imaging Biomarkers for Alzheimer’s Disease

Read More

LATEST NEWS

Mission Bio Announces Yan Zhang as New CEO

Diagnostic Laboratory Services, Inc. (DLS) Launches New Precision Medicine Program with GenomOncology’s Pathology Workbench

Cancer-Killing Virus Therapy Shows Promise Against Inoperable Skin Cancers

Invitae to acquire Genosity to accelerate access to personalized oncology testing worldwide

Magellan Rx Management and Trapelo Health to Offer Precision Oncology Platform for Next-Generation Care

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s and bluebird bio’s Abecma (idecabtagene vicleucel), the First Anti-BCMA CAR T Cell Therapy for Relapsed or Refractory Multiple Myeloma

Delfi Diagnostics Begins Enrollment for Prospective Lung Cancer Screening Trial ahead of Planned Commercial Test

SomaLogic, Leading AI-Data Driven Proteomics Platform for Advanced Research and Clinical applications, to Combine with CM Life Sciences II, to Drive Growth and Expand Technology Platform

Genome Medical Expands Board of Directors and Leadership Team as Demand for Genomics Telehealth Services Grows

Recent Tweets

LATEST ISSUE

ARCHIVE ISSUES

December 2020

September 2020

June 2020

March 2020

SUBSCRIBE